GRAVITAS-301: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of Itacitinib or Placebo in Combination With Corticosteroids for the Treatment of First-Line Acute Graft-Versus-Host Disease

IRB/UVA Tracking #
20051
Phase
III
Primary purpose
Treatment
Cancer PI
Leonid Volodin
Status
OPEN TO ACCRUAL